FORTRESS BIOTECH INC's ticker is and the CUSIP is 34960Q959. A total of 1 filers reported holding FORTRESS BIOTECH INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $18,000 | -14.3% | 7,200 | +22.0% | 0.00% | – |
| Q3 2021 | $21,000 | 0.0% | 5,900 | -1.7% | 0.00% | – |
| Q2 2021 | $21,000 | – | 6,000 | +599900.0% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 1 | -95.2% | 0.00% | – |
| Q1 2019 | $3,000 | +200.0% | 21 | +5.0% | 0.00% | – |
| Q4 2018 | $1,000 | -66.7% | 20 | 0.0% | 0.00% | – |
| Q3 2018 | $3,000 | -72.7% | 20 | -48.7% | 0.00% | – |
| Q2 2018 | $11,000 | +1000.0% | 39 | +116.7% | 0.00% | – |
| Q1 2018 | $1,000 | – | 18 | -71.0% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 62 | -1.6% | 0.00% | – |
| Q4 2016 | $3,000 | +50.0% | 63 | -77.1% | 0.00% | – |
| Q3 2016 | $2,000 | +100.0% | 275 | +3337.5% | 0.00% | – |
| Q2 2016 | $1,000 | – | 8 | -73.3% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 30 | -40.0% | 0.00% | – |
| Q4 2015 | $1,000 | – | 50 | +1566.7% | 0.00% | – |
| Q2 2015 | $0 | – | 3 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |